Polar Capital Holdings PLC Biomea Fusion, Inc. Transaction History

Polar Capital Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 13, 2023	SELL	$21.66 - $41.8 $7.26 Million - $14 Million	-335,000 Reduced 57.26%	250,000 $5.49 Million
Q2 2023 Aug 14, 2023	SELL	$21.66 - $41.8 $7.26 Million - $14 Million	-335,000 Reduced 57.26%	250,000 $5.49 Million
Q1 2023 Dec 13, 2023	BUY	$6.8 - $32.35 $2.28 Million - $10.8 Million	335,000 Added 134.0%	585,000 $18.1 Million
Q1 2023 May 15, 2023	BUY	$6.8 - $32.35 $578,000 - $2.75 Million	85,000 Added 17.0%	585,000 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$9.51 - $13.61 $4.44 Million - $6.35 Million	466,845 Added 1408.07%	500,000 $4.89 Million
Q2 2022 Aug 15, 2022	BUY	$3.0 - $12.03 $99,465 - $398,854	33,155 New	33,155 $397,000

104

17.8M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $117M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.